Last reviewed · How we verify
Surfactant
At a glance
| Generic name | Surfactant |
|---|---|
| Also known as | Survanta, Less Invasive Surfactant Administration Technique, Curosurf, BLES® Surfactant, BLEScath™ |
| Sponsor | Sood, Beena G., MD, MS |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Pragmatic Evaluation of Respiratory Distress Syndrome Treatment in Africa (PHASE4)
- SHAPE Pilot Trial: Skin Health and Allergy Prevention Exposure (NA)
- Hydroxychloroquin (HCQ) in chILD of Genetic Defect (NA)
- A National Registry For Pulmonary Alveolar Proteinosis
- Vojta Reflex Versus Lung Squeezing Technique in Respiratory Distress Preterm Neonate (NA)
- Premedication for Less Invasive Surfactant Administration Study (PRELISA) (PHASE4)
- Hydroxychloroquine in Children's Interstitial Lung Diseases With Genetic Causes (EARLY_PHASE1)
- Immunomodulatory Treatment of Interstitial Lung Disease Associated With Surfactant Related Gene Variants (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Surfactant CI brief — competitive landscape report
- Surfactant updates RSS · CI watch RSS
- Sood, Beena G., MD, MS portfolio CI